Drug products: Activelle, Activelle®, Cliovelle, Estalis, Estalis®, Eviana, Femanor®, Femasekvens®, Kliogest®, Mini-Pe®, Noresmea, Noriday, Novofem®, Orthonett® Novum, Primolut®-Nor, Sequidot®, Synfase®, Synfase® 28, Synphase, Triella, Trinovum, Trinovum®, Trinovum® 28, Trisekvens, Trisekvens®
ATC code: G03AA05, G03AB04, G03AC01, G03DC02, G03FA01, G03FB05
As the substance is only used by women, analyses on sex or gender differences have not been considered relevant.
The approved indication for noretistherone alone or in combination with ethinylestradiol or estradiol is contraception [1-2]. Experimentally, the substance has been used by men in clinical studies of anticonception, commonly in combination with testosterone [3-4].
Date of litterature search: 2017-06-22
Reviewed by: Mia von Euler
Approved by: Karin Schenck-Gustafsson